Form 4: HealthEquity EVP Sells Shares for Tax Obligations

HealthEquity's EVP, Chief Commercial Officer, Michael Henry Fiore, disposed of 1,744 shares of common stock to cover tax withholding obligations at a price of $95.2361 per share.

Summary

• Michael Henry Fiore, EVP, Chief Commercial Officer of HealthEquity, Inc. (HQY), reported a transaction.
• The transaction involved the disposition of 1,744 shares of HealthEquity Common Stock.
• The shares were disposed of at a price of $95.2361 per share.
• This disposition was made to satisfy tax withholding obligations.
• The transaction occurred on January 9, 2026.
• Following this transaction, Mr. Fiore beneficially owns 48,051 shares of Common Stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction for tax purposes, pre-scheduled under a 10b5-1 plan, and does not reflect a change in management's outlook on the company.

Future Outlook

NA

Industry Context

This transaction is a routine insider disclosure and does not provide specific insights into broader industry trends or competitive dynamics within the health savings account or benefits administration sector.

Related Party Transactions

• The transaction involves an executive (Michael Henry Fiore) of HealthEquity, Inc. disposing of company stock, which is inherently a related party transaction in the context of insider reporting.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, pre-scheduled transaction for tax purposes and not a discretionary sale indicating a change in confidence.
• No direct impact on employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled disposition of shares by an executive to cover tax withholding obligations. Such transactions, particularly when executed under a Rule 10b5-1 plan, typically do not signal a change in the executive's confidence in the company's future prospects or warrant a change in investment recommendation. Therefore, a 'hold' recommendation remains appropriate based solely on this filing, as it provides no new material information to alter the investment thesis.

Keywords

HealthEquity, HQY, Insider Trading, Form 4, Stock Sale, Executive Compensation, Tax Withholding, Michael Fiore, Common Stock